202 related articles for article (PubMed ID: 21457141)
1. In silico identification of microRNAs predicted to regulate the drug metabolizing cytochrome P450 genes.
Ramamoorthy A; Skaar TC
Drug Metab Lett; 2011 Apr; 5(2):126-31. PubMed ID: 21457141
[TBL] [Abstract][Full Text] [Related]
2. In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression.
Ramamoorthy A; Li L; Gaedigk A; Bradford LD; Benson EA; Flockhart DA; Skaar TC
Drug Metab Dispos; 2012 Apr; 40(4):726-33. PubMed ID: 22232426
[TBL] [Abstract][Full Text] [Related]
3. Variation in the expression of cytochrome P450-related miRNAs and transcriptional factors in human livers: Correlation with cytochrome P450 gene phenotypes.
Zhang HF; Zhu LL; Yang XB; Gao N; Fang Y; Wen Q; Qiao HL
Toxicol Appl Pharmacol; 2021 Feb; 412():115389. PubMed ID: 33385404
[TBL] [Abstract][Full Text] [Related]
4. Effect of miR-433-3p and miR-883b-5p on murine CYP 3A family enzymes in AML12 cells.
Sugino Y; Kugawa F
Pharmazie; 2018 Sep; 73(9):519-525. PubMed ID: 30223935
[TBL] [Abstract][Full Text] [Related]
5. [Most recent findings on microRNA-dependent regulation of drug metabolism].
Nakano M; Nakajima M
Nihon Yakurigaku Zasshi; 2019; 154(1):28-34. PubMed ID: 31308347
[TBL] [Abstract][Full Text] [Related]
6. Identification of Candidate Target Cyp Genes for microRNAs Whose Expression Is Altered by PCN and TCPOBOP, Representative Ligands of PXR and CAR.
Moriya N; Kataoka H; Nishikawa J; Kugawa F
Biol Pharm Bull; 2016 Aug; 39(8):1381-6. PubMed ID: 27237601
[TBL] [Abstract][Full Text] [Related]
7. [From the Viewpoint of Drug Metabolism Research].
Nakajima M
Yakugaku Zasshi; 2017; 137(6):697-705. PubMed ID: 28566576
[TBL] [Abstract][Full Text] [Related]
8. Identifications of conserved 7-mers in 3'-UTRs and microRNAs in Drosophila.
Gu J; Fu H; Zhang X; Li Y
BMC Bioinformatics; 2007 Nov; 8():432. PubMed ID: 17996040
[TBL] [Abstract][Full Text] [Related]
9. miRNA-mediated relationships between Cis-SNP genotypes and transcript intensities in lymphocyte cell lines.
Zhang W; Edwards A; Zhu D; Flemington EK; Deininger P; Zhang K
PLoS One; 2012; 7(2):e31429. PubMed ID: 22348086
[TBL] [Abstract][Full Text] [Related]
10. MiR-155 and other microRNAs downregulate drug metabolizing cytochromes P450 in inflammation.
Kugler N; Klein K; Zanger UM
Biochem Pharmacol; 2020 Jan; 171():113725. PubMed ID: 31758923
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 Enzymes and Drug Metabolism in Humans.
Zhao M; Ma J; Li M; Zhang Y; Jiang B; Zhao X; Huai C; Shen L; Zhang N; He L; Qin S
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884615
[TBL] [Abstract][Full Text] [Related]
12. Identification of common carp (Cyprinus carpio) microRNAs and microRNA-related SNPs.
Zhu YP; Xue W; Wang JT; Wan YM; Wang SL; Xu P; Zhang Y; Li JT; Sun XW
BMC Genomics; 2012 Aug; 13():413. PubMed ID: 22908890
[TBL] [Abstract][Full Text] [Related]
13. The Computational Analysis Conducted on miRNA Target Sites in Association with SNPs at 3'UTR of ADHD-implicated Genes.
Abdi A; Zafarpiran M; Farsani ZS
Cent Nerv Syst Agents Med Chem; 2020; 20(1):58-75. PubMed ID: 31660846
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
15. Cell-type-specific signatures of microRNAs on target mRNA expression.
Sood P; Krek A; Zavolan M; Macino G; Rajewsky N
Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2746-51. PubMed ID: 16477010
[TBL] [Abstract][Full Text] [Related]
16. In silico analysis of microRNAS targeting the HLA-G 3' untranslated region alleles and haplotypes.
Castelli EC; Moreau P; Oya e Chiromatzo A; Mendes-Junior CT; Veiga-Castelli LC; Yaghi L; Giuliatti S; Carosella ED; Donadi EA
Hum Immunol; 2009 Dec; 70(12):1020-5. PubMed ID: 19664672
[TBL] [Abstract][Full Text] [Related]
17. SNP Regulation of microRNA Expression and Subsequent Colon Cancer Risk.
Mullany LE; Wolff RK; Herrick JS; Buas MF; Slattery ML
PLoS One; 2015; 10(12):e0143894. PubMed ID: 26630397
[TBL] [Abstract][Full Text] [Related]
18. Novel SNPs in cytochrome P450 oxidoreductase.
Hart SN; Li Y; Nakamoto K; Wesselman C; Zhong XB
Drug Metab Pharmacokinet; 2007 Aug; 22(4):322-6. PubMed ID: 17827787
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
Manikandan P; Nagini S
Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
[TBL] [Abstract][Full Text] [Related]
20. Human drug metabolism and the cytochromes P450: application and relevance of in vitro models.
Venkatakrishnan K; Von Moltke LL; Greenblatt DJ
J Clin Pharmacol; 2001 Nov; 41(11):1149-79. PubMed ID: 11697750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
